Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...
Mario Hose | September 18, 2020 |

Where’s the Bottom? – Cycles Paint A Clear Picture

Has the selloff ended? When will it end? What will the bottom look like and am I at risk of taking further losses? What should I do? Do you want to take a guess at how many of our friends and family members are calling us over the past week or so asking these questions? Pe...
Chris Vermeulen | March 13, 2020 |

Black Monday 1987 vs 2019 - Part II

Our research team has been attempting to answer the question that seems to be on everyone's minds right now – are we setting up another Black Monday type of event in the global markets and what should traders/investors know before the event potentially takes place. Our researc...
Chris Vermeulen | October 21, 2019 |

Here Comes Another $2T Support for Stocks

In anticipation of the previous $2T stimulus package that passed on Mar 27 and in its aftermath, stocks rallied, yet it wasn’t a one-way road. They had trouble overcoming the pre-stimulus highs, and actually sold off in the following week. Today&CloseCurly...
Monica Kingsley | April 9, 2020 |

Natural Gas Continues To Offer Opportunities for Longs

Historically, April has been a pretty consistent upside opportunity in Natural Gas for over 20 years. Over the past 24+ years, the upside opportunity in Natural Gas has been accurate over 68% of the time with the average upside potential ranging from $0.60 to $0.85. With Natur...
Chris Vermeulen | April 11, 2019 |

The Euro Rests at Support As We Count Our Hefty AUD Profits

Our open position in the Australian dollar has been closed, and at a sizable profit. But the countdown to tomorrow’s Fed is on, and it pays not to rest on laurels. The setups in the other currency pairs won’t wait, so let’s get d...
Nadia Simmons | July 31, 2019 |

Will Global Slowdown Support Gold, or Is It Just Temporary?

Mayday, mayday, we are sinking! The global economy is slowing down. How serious is the current slump? We invite you to read our today’s article about the true condition of the world’s economy and find out what are its likely implications fo...
Arkadiusz Sieron | April 5, 2019 |

S&P 500 Nearing Previous Highs, What’s Next?

Wednesday’s trading session didn’t change much. Stocks extended their short-term consolidation following Monday’s rebound off a support level. The S&P 500 index continues to trade within a four-week-long consolidation after the e...
Paul Rejczak | August 29, 2019 |

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer

Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. This morning Durham, N.C.-based Dova Pharmaceuticals Inc. (DOVA:NASDAQ) announced ...
Streetwise Reports | October 1, 2019 |

S&P 500: Negative Expectations Again

Stocks were gaining on Friday following a lower opening of the trading session and the morning sell-off. The S&P 500 index extended its downtrend before bouncing off and closing 0.4% higher. So was it an upward reversal or just correction within a downtrend? S&P 500: Negati...
Paul Rejczak | May 13, 2019 |
1 2 3 4 5 6 7 8 9 10 ...